ZE94-0605

N/A

Report date: 2026/04/14 20:00:15
NME

Base Information

Drug NameZE94-0605
Drug Alias NameZE94-0605
ClassificationSmall molecules
Mechanisms of ActionCyclin-dependent kinase 2 inhibitors
TargetsCyclin-dependent kinase 2
Therapy Area/IndicationsSolid tumoursBrain NeoplasmsOvarian Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesEilean Therapeutics LLCChemDiv IncPadarn Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesPadarn Therapeutics IncEilean Therapeutics LLCChemDiv Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursBrain NeoplasmsOvarian Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A